Literature DB >> 8099381

Effects of human growth hormone therapy on melanocytic naevi.

J P Bourguignon1, G E Piérard, C Ernould, C Heinrichs, M Craen, P Rochiccioli, J E Arrese, C Franchimont.   

Abstract

Melanocytic naevi may grow more rapidly during human growth hormone (hGH) therapy. With standardised skin photographs, the growth rate of the naevi was two-fold greater in 14 hypopituitary and 5 Turner's syndrome girls treated with hGH than in untreated patients or controls. HMB-45 immunoreactivity, a marker of stimulated melanocytes, was absent in naevi from 18 of 19 individuals not treated with hGH, including 5 Turner's syndrome patients studied 2-43 months after stopping hGH. In naevi from 39 hGH-treated patients, 22 showed unusual HMB-45 reactivity in dermal naevocytes. During administration of hGH, melanocytic naevi grow faster and there is reversible stimulation of naevocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099381     DOI: 10.1016/0140-6736(93)90636-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Growth hormone treatment in Turner syndrome.

Authors:  A Zvulunov
Journal:  Eur J Pediatr       Date:  1994-12       Impact factor: 3.183

2.  Childhood melanoma in Australia.

Authors:  W R McWhirter; C Dobson
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

3.  The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?

Authors:  Edward O List; Darlene E Berryman; Reetobrata Basu; Mathew Buchman; Kevin Funk; Prateek Kulkarni; Silvana Duran-Ortiz; Yanrong Qian; Elizabeth A Jensen; Jonathan A Young; Gozde Yildirim; Shoshana Yakar; John J Kopchick
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

4.  Turner syndrome and associated problems in Turkish children: a multicenter study.

Authors:  Ediz Yeşilkaya; Abdullah Bereket; Feyza Darendeliler; Firdevs Baş; Şükran Poyrazoğlu; Banu Küçükemre Aydın; Şükran Darcan; Bumin Dündar; Muammer Büyükinan; Cengiz Kara; Erkan Sarı; Erdal Adal; Ayşehan Akıncı; Mehmet Emre Atabek; Fatma Demirel; Nurullah Çelik; Behzat Özkan; Bayram Özhan; Zerrin Orbak; Betül Ersoy; Murat Doğan; Ali Ataş; Serap Turan; Damla Gökşen; Ömer Tarım; Bilgin Yüksel; Oya Ercan; Şükrü Hatun; Enver Şimşek; Ayşenur Ökten; Ayhan Abacı; Hakan Döneray; Mehmet Nuri Özbek; Mehmet Keskin; Hasan Önal; Nesibe Akyürek; Kezban Bulan; Derya Tepe; Hamdi Cihan Emeksiz; Korcan Demir; Deniz Kızılay; Ali Kemal Topaloğlu; Erdal Eren; Samim Özen; Saygın Abalı; Leyla Akın; Beray Selver Eklioğlu; Sultan Kaba; Ahmet Anık; Serpil Baş; Tolga Ünüvar; Halil Sağlam; Semih Bolu; Tolga Özgen; Durmuş Doğan; Esra Deniz Çakır; Yaşar Şen; Nesibe Andıran; Filiz Çizmecioğlu; Olcay Evliyaoğlu; Gülay Karagüzel; Özgür Pirgon; Gönül Çatlı; Hatice Dilek Can; Fatih Gürbüz; Çiğdem Binay; Veysel Nijat Baş; Kürşat Fidancı; Adem Polat; Davut Gül; Cengizhan Açıkel; Hüseyin Demirbilek; Peyami Cinaz; Carolyn Bondy
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-03

5.  Associated clinical abnormalities among patients with Turner syndrome.

Authors:  Suna Kilinc; Metin Yildiz; Ayla Guven
Journal:  North Clin Istanb       Date:  2020-04-14

6.  Effects of Growth Hormone (GH) Supplementation on Dermatoscopic Evolution of Pigmentary Lesions in Children with Growth Hormone Deficiency (GHD).

Authors:  Fabrizio Panarese; Giulio Gualdi; Marta Di Nicola; Cosimo Giannini; Nella Polidori; Federica Giuliani; Angelika Mohn; Paolo Amerio
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

7.  Hypertrophic scars in a patient with Turner's syndrome treated with recombinant growth hormone.

Authors:  Andrzej Kędzia; Mariola Pawlaczyk; Elżbieta Petriczko
Journal:  Postepy Dermatol Alergol       Date:  2014-04-22       Impact factor: 1.837

Review 8.  Simulants of Malignant Melanoma.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Philippe Delvenne
Journal:  Oncol Rev       Date:  2015-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.